Peter Friedli is Director at OSIRIS THERAPEUTICS, INC. (OSIR). They have made 5 open-market trades across 1 company since 2007, most recently 2019-04-17.
CIK 0001008317
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $26.4M since 2007, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| OSIR | 10,204,404 | — |
Shares reported on the most recent Form 4, priced at the 2014-02-07 close. 1 holding could not be priced and is excluded from the total.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.